---
title: "Prenosis secures $20M BARDA contract & $20M Series A funding, advancing innovation in critical care diagnostics & therapeutics."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274173369.md"
description: "Prenosis has secured a $20 million contract with BARDA and $20 million in Series A funding, aimed at enhancing innovation in critical care diagnostics and therapeutics. The company, based in Chicago, focuses on biology-based solutions for critical care conditions. These developments, announced on January 29, 2026, are expected to accelerate advancements in healthcare, particularly in diagnostics and therapies for critical care needs."
datetime: "2026-01-29T15:07:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274173369.md)
  - [en](https://longbridge.com/en/news/274173369.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274173369.md)
---

# Prenosis secures $20M BARDA contract & $20M Series A funding, advancing innovation in critical care diagnostics & therapeutics.

Prenosis, a cutting-edge technology company focusing on biology-based diagnostics and therapeutics for critical care conditions, has recently made significant progress through its latest fundraising endeavors in Chicago. The company, which aims to revolutionize healthcare through integrated solutions, unveiled two key announcements on January 29, 2026. This successful round of funding is set to accelerate innovation in the field, with a focus on developing advanced diagnostics and therapies to address critical care needs. Keep an eye on Prenosis as they continue to drive forward in this essential sector.

### Related Stocks

- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [GNPX.US](https://longbridge.com/en/quote/GNPX.US.md)
- [PRENW.US](https://longbridge.com/en/quote/PRENW.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)

## Related News & Research

- [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md)
- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [IT Sector Accounts for Nearly One Third of U.S. Securities Litigation Risk in 1H 2026](https://longbridge.com/en/news/294507902.md)
- [Biotech experts want FDA drug reviews based on science, not politics](https://longbridge.com/en/news/293453841.md)
- [Has the bull market shifted to biotech stocks?](https://longbridge.com/en/news/293077044.md)